Medclair AB Statistics

Total Valuation

Medclair AB has a market cap or net worth of SEK 215.37 million. The enterprise value is 209.63 million.

Market Cap	215.37M
Enterprise Value	209.63M

Important Dates

The next estimated earnings date is Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

Medclair AB has 91.65 million shares outstanding. The number of shares has decreased by -9.87% in one year.

Current Share Class	91.65M
Shares Outstanding	91.65M
Shares Change (YoY)	-9.87%
Shares Change (QoQ)	-11.55%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 39.17.

PE Ratio	39.17
Forward PE	n/a
PS Ratio	3.84
PB Ratio	4.01
P/TBV Ratio	6.39
P/FCF Ratio	31.18
P/OCF Ratio	30.78
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.13, with an EV/FCF ratio of 30.35.

EV / Earnings	45.05
EV / Sales	3.74
EV / EBITDA	20.13
EV / EBIT	36.78
EV / FCF	30.35

Financial Position

The company has a current ratio of 3.06

Current Ratio	3.06
Quick Ratio	1.64
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	9.74

Financial Efficiency

Return on equity (ROE) is 9.06% and return on invested capital (ROIC) is 11.17%.

Return on Equity (ROE)	9.06%
Return on Assets (ROA)	5.91%
Return on Invested Capital (ROIC)	11.17%
Return on Capital Employed (ROCE)	10.62%
Weighted Average Cost of Capital (WACC)	9.11%
Revenue Per Employee	3.74M
Profits Per Employee	310,200
Employee Count	14
Asset Turnover	0.93
Inventory Turnover	2.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.13% in the last 52 weeks. The beta is 0.88, so Medclair AB's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	+52.13%
50-Day Moving Average	2.45
200-Day Moving Average	2.74
Relative Strength Index (RSI)	46.68
Average Volume (20 Days)	95,082

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medclair AB had revenue of SEK 56.07 million and earned 4.65 million in profits. Earnings per share was 0.06.

Revenue	56.07M
Gross Profit	38.04M
Operating Income	5.70M
Pretax Income	4.65M
Net Income	4.65M
EBITDA	10.41M
EBIT	5.70M
Earnings Per Share (EPS)	0.06

Full Income Statement

Balance Sheet

The company has 5.74 million in cash and n/a in debt, giving a net cash position of 5.74 million or 0.06 per share.

Cash & Cash Equivalents	5.74M
Total Debt	n/a
Net Cash	5.74M
Net Cash Per Share	0.06
Equity (Book Value)	53.69M
Book Value Per Share	0.65
Working Capital	14.42M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.00 million and capital expenditures -90,000, giving a free cash flow of 6.91 million.

Operating Cash Flow	7.00M
Capital Expenditures	-90,000
Depreciation & Amortization	4.71M
Net Borrowing	n/a
Free Cash Flow	6.91M
FCF Per Share	0.08

Full Cash Flow Statement

Margins

Gross margin is 67.85%, with operating and profit margins of 10.16% and 8.30%.

Gross Margin	67.85%
Operating Margin	10.16%
Pretax Margin	8.30%
Profit Margin	8.30%
EBITDA Margin	18.57%
EBIT Margin	10.16%
FCF Margin	12.32%

Dividends & Yields

Medclair AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	9.87%
Shareholder Yield	9.87%
Earnings Yield	2.16%
FCF Yield	3.21%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medclair AB has an Altman Z-Score of 17.42 and a Piotroski F-Score of 7.

Altman Z-Score	17.42
Piotroski F-Score	7